Beijing Health (Holdings) Limited (HK:2389)
:2389
Top Page
Beijing Health (Holdings) Limited
(2389)
Select Model
Select Model
Rating:43Neutral
Price Target:
HK$0.06
▲(0.00% Upside)
Action:ReiteratedDate:10/25/25
The overall stock score is primarily influenced by the company's financial challenges, including declining revenues and persistent losses. Technical analysis indicates bearish momentum, and valuation metrics are unattractive due to negative earnings and lack of dividends.
Positive Factors
Low leverage & strong cash buffer
Extremely low leverage and a sizeable cash balance provide durable financial flexibility. This reduces interest burdens, supports ongoing R&D and operating needs, and gives the company runway to execute restructuring or product investments without immediate refinancing, improving resilience.
Negative Factors
Persistent net losses
Large negative net income erodes retained earnings and prevents reinvestment from internal profits. Continued losses undermine ROE, may require external capital, and increase strategic constraints; profitability turnaround is necessary for long-term financial health.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage & strong cash buffer
Extremely low leverage and a sizeable cash balance provide durable financial flexibility. This reduces interest burdens, supports ongoing R&D and operating needs, and gives the company runway to execute restructuring or product investments without immediate refinancing, improving resilience.
Read all positive factors
Beijing Health (Holdings) Limited (2389) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$381.70M
Dividend YieldN/A
Average Volume (3M)1.21M
Price to Earnings (P/E)―
Beta (1Y)0.13
Revenue Growth12.99%
EPS Growth13.02%
CountryHK
Employees179
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)-0.01
Shares Outstanding6,058,772,000
10 Day Avg. Volume988,800
30 Day Avg. Volume1,211,200
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)0.27
Price to Sales (P/S)3.11
P/FCF Ratio-11.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Beijing Health (Holdings) Limited Business Overview & Revenue Model
Company Description
Beijing Health (Holdings) Limited, an investment holding company, provides medical, health, and geriatric care related services and products in the People's Republic of China. The company also engages in owning and developing general health indust...
How the Company Makes Money
Beijing Health (Holdings) Limited generates revenue through several key streams, including the sale of pharmaceutical products, which encompass traditional Chinese medicine and contemporary pharmaceuticals. The company leverages its research and d...
Beijing Health (Holdings) Limited Financial Statement Overview
Summary
Income Statement
40
Negative
Balance Sheet
55
Neutral
Cash Flow
45
Neutral
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 153.22M | 149.94M | 140.35M | 166.48M | 203.78M | 149.89M |
| Gross Profit | 39.69M | 35.68M | 38.47M | 46.51M | 46.99M | 32.79M |
| EBITDA | -56.17M | -97.47M | -44.19M | -75.25M | -10.37M | -122.87M |
| Net Income | -89.04M | -116.22M | -61.88M | -97.70M | -39.41M | -185.32M |
Balance Sheet | ||||||
| Total Assets | 1.92B | 1.95B | 2.18B | 2.42B | 2.84B | 2.81B |
| Cash, Cash Equivalents and Short-Term Investments | 258.81M | 211.08M | 335.96M | 440.76M | 496.30M | 504.63M |
| Total Debt | 6.23M | 5.65M | 4.89M | 32.75M | 48.37M | 41.64M |
| Total Liabilities | 199.43M | 209.74M | 223.82M | 271.77M | 341.34M | 317.57M |
| Stockholders Equity | 1.69B | 1.72B | 1.89B | 2.04B | 2.29B | 2.28B |
Cash Flow | ||||||
| Free Cash Flow | 10.30M | -42.20M | -45.10M | -12.34M | 406.00K | 17.02M |
| Operating Cash Flow | 19.10M | -35.56M | -43.72M | -11.19M | 1.99M | 26.73M |
| Investing Cash Flow | -9.42M | -33.80M | 74.76M | 22.77M | -227.83M | 122.22M |
| Financing Cash Flow | -4.64M | -5.28M | -68.40M | -17.71M | -20.46M | -83.56M |
Beijing Health (Holdings) Limited Technical Analysis
Negative
0.06
Price Trends
0.06
Negative
0.07
Negative
0.08
Negative
Market Momentum
>-0.01
Positive
42.79
Neutral
22.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2389, the sentiment is Negative. The current price of 0.06 is below the 20-day moving average (MA) of 0.07, below the 50-day MA of 0.06, and below the 200-day MA of 0.08, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 42.79 is Neutral, neither overbought nor oversold. The STOCH value of 22.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2389.
Beijing Health (Holdings) Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$364.43M | 4.98 | 4.28% | 7.10% | -2.88% | -22.83% | |
71 Outperform | HK$678.82M | 3.30 | 5.29% | 9.14% | 0.47% | 50.46% | |
60 Neutral | HK$490.00M | 4.08 | 5.27% | 4.49% | 20.85% | -66.81% | |
56 Neutral | HK$545.87M | 5.00 | 31.63% | ― | 2.30% | ― | |
54 Neutral | HK$248.93M | -2.55 | -25.22% | 3.16% | -21.31% | -149.92% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
43 Neutral | HK$381.70M | -3.84 | -6.02% | ― | 12.99% | 13.02% |
* Healthcare Sector Average
HK:2389
Beijing Health (Holdings) Limited
0.06
-0.01
-17.11%
HK:1518
New Century Healthcare Holding Co. Ltd.
0.51
-0.59
-53.64%
HK:2189
Kato (Hong Kong) Holdings Ltd.
0.49
0.06
13.95%
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
2.03
0.22
12.15%
HK:3869
Hospital Corporation of China Ltd
3.95
-2.85
-41.91%
HK:0722
UMP Healthcare Holdings Limited
0.46
0.09
23.64%
Beijing Health (Holdings) Limited Corporate Events
Beijing Health (Holdings) Unveils Board Line-up and Committee Structure
Jan 30, 2026
Beijing Health (Holdings) Limited has announced the composition of its board of directors, which consists of four executive directors, led by chairman Zhu Shi Xing and chief executive officer Liu Xue Heng, and four independent non-executive direct...
Beijing Health Redeems HKD20.2 Million from CUAM USD Money Market Fund
Jan 22, 2026
Beijing Health (Holdings) Limited has redeemed its entire holding of 1,812,940.7712 units in the CUAM USD Money Market Fund (Class P), receiving approximately HKD20.2 million in cash proceeds, slightly above its original HKD20 million subscription...
Beijing Health Unit Exits Investment Fund With US$1 Million Gain
Dec 31, 2025
Beijing Health (Holdings) Limited has announced that its indirect wholly owned subsidiary, China Vista Capital Holding Limited, has fully redeemed its 8,020.99 Class A shares in BE Fortune Diversified Income Fund SP 2 for approximately US$10.9 mil...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.